Summary
- Current Price
- As of today, NGEN price is $1.51, up +11.84% in the most recent trading session on
- Current Price All-Time High
- NGEN price is currently -76.03% below its historical high of $6.30 set on
- Market Cap
- NGEN current market cap is $162M, down -17.91% year-over-year
- Revenue
- NGEN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for NGEN is on
Profile
| Metric | Value |
|---|---|
| Full Name | NervGen Pharma Corp. |
| Ticker | NASDAQ: NGEN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | nervgen.com |
| Employees | 8 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.51 | ||
| Price, 1D Change | +11.84% | |
| $162M | ||
| - | ||
| - | ||
| 1.73 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.44 | ||
| EPS, 1Y Change | -66.03% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.44 | ||
| EPS Estimate | - | N/A |
| EPS Est. Change | - | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $1.51 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.28 | - | |
| - | -$0.26 | - | |
| - | -$0.44 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -43.95% | ||
| +11.02% | ||
| -17.91% | ||
| +100.61% | ||
| 0.00% | ||
| 0.00% | ||
| -66.03% | ||
| -44.39% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.51 | ||
| $2.69 | ||
| $1.76 | ||
| $2.36 | ||
| $1.65 | ||
| -$0.11 | ||
| 1.73 | ||
| $0.10 | ||
| 35.66 | ||
| 51.63% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.44 | ||
| -$39.90K | ||
| - | ||
| -$17.95M | ||
| - | ||
| -$31.57M | ||
| - | ||
| -$17.91M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 1.16 | ||
| 1.16 | ||
| - | ||
| - | ||
| -5.43 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.92 | ||
| -4.38 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $2.54M | ||
| $16.11M | ||
| $16.93M | ||
| $16.63M | ||
| $14.40M | ||
| $14.40M | ||
| $6,100.00 | ||
| $6,100.00 | ||
| $0.00 |
Expenses
| Metric | Value | Date |
|---|---|---|
| $31.57M | ||
| $17.91M | ||
| $39.90K | ||
| $0.00 | ||
| $39.90K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$13.96M | ||
| $72.20K | ||
| $17.01M | ||
| $0.00 | ||
| -$13.96M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Leerink Partners | ||
| HC Wainwright & Co. |
Analyst sentiment
Institutional ownership
Screeners with NGEN
FAQ
- What is the ticker symbol for NervGen Pharma Corp.?
- The ticker symbol for NervGen Pharma Corp. is NASDAQ:NGEN
- Does NervGen Pharma Corp. pay dividends?
- No, NervGen Pharma Corp. does not pay dividends
- What sector is NervGen Pharma Corp. in?
- NervGen Pharma Corp. is in the Healthcare sector
- What industry is NervGen Pharma Corp. in?
- NervGen Pharma Corp. is in the Biotechnology industry
- What country is NervGen Pharma Corp. based in?
- NervGen Pharma Corp. is headquartered in Canada
- When did NervGen Pharma Corp. go public?
- NervGen Pharma Corp. initial public offering (IPO) was on February 8, 2021
- Is NervGen Pharma Corp. in the S&P 500?
- No, NervGen Pharma Corp. is not included in the S&P 500 index
- Is NervGen Pharma Corp. in the NASDAQ 100?
- No, NervGen Pharma Corp. is not included in the NASDAQ 100 index
- Is NervGen Pharma Corp. in the Dow Jones?
- No, NervGen Pharma Corp. is not included in the Dow Jones index
- When was NervGen Pharma Corp. last earnings report?
- NervGen Pharma Corp.'s most recent earnings report was on August 13, 2026
- When does NervGen Pharma Corp. report earnings?
- The next expected earnings date for NervGen Pharma Corp. is November 23, 2026
Data Sources & References
- NGEN Official Website www.nervgen.com
- NGEN Profile on Yahoo Finance finance.yahoo.com/quote/NGEN
- NGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ngen